The Development and Validation of the Smell-Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, systematický přehled, validační studie
PubMed
40344493
PubMed Central
PMC12401079
DOI
10.1002/alr.23604
Knihovny.cz E-zdroje
- Klíčová slova
- gustatory dysfunction, olfactory dysfunction, patient‐reported outcome measures,
- MeSH
- čich MeSH
- dospělí MeSH
- hodnocení výsledků péče pacientem MeSH
- klinické zkoušky jako téma MeSH
- kvalita života MeSH
- lidé středního věku MeSH
- lidé MeSH
- poruchy chuti * diagnóza MeSH
- poruchy čichu * diagnóza MeSH
- průzkumy a dotazníky MeSH
- reprodukovatelnost výsledků MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- systematický přehled MeSH
- validační studie MeSH
BACKGROUND: Olfactory dysfunction affects up to 22% of the population. Accurate assessment is vital for diagnosis and tracking outcomes, often using patient-reported outcome measures (PROMs). AIMS: We aimed to develop and validate a novel questionnaire for assessing olfactory and gustatory dysfunction. METHODS: A systematic review identified existing smell and taste questionnaires, followed by item generation and selection. After two Delphi cycles and consultation with a large panel of smell and taste experts, the Smell-Qx questionnaire was developed. A validation study recruited patients from smell and taste clinics (cases) and general ENT clinics (controls) to complete the Smell-Qx. Additionally, patients with smell and taste disorders underwent psychophysical testing using Sniffin' Stick Threshold, Discrimination, and Identification (TDI) tests. RESULTS: The Smell-Qx is an 11-domain instrument, with five core domains used for total score calculation and six history/quality-of-life domains for obtaining a comprehensive history. The validation study recruited 60 participants (32 patients with smell/taste disorders and 28 controls). Items showed acceptable to significant internal consistency (Cronbach's α: 0.64-0.97) and test-retest reliability (ICC: 0.65-0.99, p < 0.001). The Smell-Qx was effective at distinguishing patients with smell and taste disorders from controls (t = 9.99, df = 58, p < 0.0001). Concurrent criterion validity was good with overall SATD-related quality of life (r = 0.43, p = 0.015), as well as with the smell loss domain and overall smell TDI scores (r = -0.54, p = 0.011). CONCLUSION: The Smell-Qx is a reliable and valid PROM for assessing olfactory and self-reported gustatory disorders, capturing symptom severity and quality-of-life impact. It can integrate into a multi-modal assessment approach alongside psychophysical testing.
2nd Academic ORL Department Aristotle University of Thessaloniki Thessaloniki Greece
Department of Anatomy Université du Québec à Trois Rivières Trois Rivières Quebec Canada
Department of Clinical Medicine Aarhus University Øre Næse og Halskirurgi RHG Aarhus N Denmark
Department of Otolaryngology Head and Neck Surgery Harvard Medical School Boston USA
Department of Otorhinolaryngology Head and Neck Surgery Medical University of Vienna Vienna Austria
Department of Otorhinolaryngology Head and Neck Surgery University Hospital Basel Basel Switzerland
Department of Otorhinolaryngology Hospital Clínic Barcelona Barcelona Spain
Department of Otorhinolaryngology Jikei University School of Medicine Tokyo Japan
Department of Surgery The University of Chicago Chicago Illinois USA
Division of Surgery and Interventional Science UCL London UK
ENT Department ASST Sette Laghi University of Insubria Varese Italy
Massachusetts Eye and Ear Boston USA
Royal National Ear Nose Throat and Eastman Dental Hospitals London UK
Sheffield Children's Hospital Sheffield UK
UCL Cancer Institute London UK
UCL Ear Institute University College London London UK
University of East Anglia Medical School University of East Anglia Norwich UK
Zobrazit více v PubMed
Langstaff L., Pradhan N., Clark A., et al., “Validation of the Olfactory Disorders Questionnaire for English‐Speaking Patients With Olfactory Disorders,” Clinical Otolaryngology 44, no. 5 (2019): 715–728, 10.1111/coa.13351. PubMed DOI
Hernandez A. K., Landis B., Altundag A., et al., “Olfactory Nomenclature: An Orchestrated Effort to Clarify Terms and Definitions of Dysosmia, Anosmia, Hyposmia, Normosmia, Hyperosmia, Olfactory Intolerance, Parosmia, and Phantosmia/Olfactory Hallucination,” Orl; Journal for Oto‐Rhino‐Laryngology and Its Related Specialties (2023): 1–9, 10.1159/000530211. PubMed DOI PMC
Whitcroft K. L., Altundag A., Balungwe P., et al., “Position Paper on Olfactory Dysfunction: 2023,” Rhinology 61, no. 33 (2023): 1–131, 10.4193/rhin22.483. PubMed DOI
Patel Z. M., Holbrook E. H., Turner J. H., et al., “International Consensus Statement on Allergy and Rhinology: Olfaction,” International Forum of Allergy & Rhinology 12, no. 4 (2022): 327–380, 10.1002/alr.22929. PubMed DOI PMC
Mullol J., Alobid I., Marino‐Sanchez F., et al., “Furthering the Understanding of Olfaction, Prevalence of Loss of Smell and Risk Factors: A Population‐Based Survey (OLFACAT Study),” BMJ Open 2, no. 6 (2012): e001256, 10.1136/bmjopen-2012-001256. PubMed DOI PMC
Liu G., Zong G., Doty R. L., et al., “Prevalence and Risk Factors of Taste and Smell Impairment in a Nationwide Representative Sample of the US Population: A Cross‐Sectional Study,” BMJ Open 6 (2016): e013246, 10.1136/bmjopen-2016-013246. PubMed DOI PMC
Lechner M., Liu J., Counsell N., et al., “High Prevalence of Persistent Smell Loss and Qualitative Smell Dysfunction During the COVID‐19 Pandemic in the United States: Urgent Need for Clinical Trials,” International Forum of Allergy & Rhinology 13 (2023): 1558–1560, 10.1002/alr.23100. PubMed DOI PMC
Lechner M., Liu J., Counsell N., et al., “The COVANOS Trial—Insight Into Post‐COVID Olfactory Dysfunction and the Role of Smell Training,” Rhinology 60, no. 3 (2022): 188–199, 10.4193/rhin21.470. PubMed DOI
Welge‐Luessen A., Hummel T., Stojan T., and Wolfensberger M., “What Is the Correlation Between Ratings and Measures of Olfactory Function in Patients With Olfactory Loss?,” American Journal of Rhinology 19, no. 6 (2005): 567–571, 10.1177/194589240501900606. PubMed DOI
Hummel T., Kobal G., Gudziol H., et al., “Normative Data for the “Sniffin' Sticks” Including Tests of Odor Identification, Odor Discrimination, and Olfactory Thresholds: An Upgrade Based on a Group of More Than 3,000 Subjects,” European Archives of Oto‐Rhino‐Laryngology 264, no. 3 (2006): 237–243, 10.1007/s00405-006-0173-0. PubMed DOI
Ta N. H., Gao J., and Philpott C., “A Systematic Review to Examine the Relationship Between Objective and Patient‐Reported Outcome Measures in Sinonasal Disorders: Recommendations for Use in Research and Clinical Practice,” International Forum of Allergy & Rhinology 11, no. 5 (2021): 910–923, 10.1002/alr.22744. PubMed DOI PMC
Han P., Su T., Qin M., et al., “A Systematic Review of Olfactory Related Questionnaires and Scales,” Rhinology 59 (2021): 133–143, 10.4193/rhin20.291. PubMed DOI
Landis B. N., “Ratings of Overall Olfactory Function,” Chemical Senses 28, no. 8 (2003): 691–694, 10.1093/chemse/bjg061. PubMed DOI
Wrobel B. B. and Leopold D. A., “Clinical Assessment of Patients With Smell and Taste Disorders,” Otolaryngologic Clinics of North America 37, no. 6 (2004): 1127–1142, 10.1016/j.otc.2004.06.010. PubMed DOI PMC
Croy I., Hoffmann H., Philpott C., et al., “Retronasal Testing of Olfactory Function: An Investigation and Comparison in Seven Countries,” European Archives of Oto‐Rhino‐Laryngology 271, no. 5 (2014): 1087–1095, 10.1007/s00405-013-2684-9. PubMed DOI
Philpott C., Kumaresan K., Fjaeldstad A. W., et al., “Developing a Core Outcome Set for Clinical Trials in Olfactory Disorders: A COMET Initiative,” Rhinology 61, no. 4 (2023): 312–319, 10.4193/Rhin22.116. PubMed DOI
Fifth Sense , Fifth Sense – Supporting People Affected by Smell and Taste Disorders, https://www.fifthsense.org.uk/.
Hummel T., Sekinger B., Wolf S. R., et al., “Sniffin‘ Sticks’: Olfactory Performance Assessed by the Combined Testing of Odor Identification, Odor Discrimination, and Olfactory Threshold,” Chemical Senses 22, no. 1 (1997): 39–52, 10.1093/chemse/22.1.39. PubMed DOI
Ursachi G., Horodnic I. A., and Zait A., “How Reliable Are Measurement Scales?,” Procedia Economics and Finance 20 (2015): 679–686.
Gent J. F., Goodspeed R. B., Zagraniski R. T., et al., “Taste and Smell Problems: Validation of Questions for the Clinical History,” The Yale Journal of Biology and Medicine 60, no. 1 (1987): 27–35. PubMed PMC
Nordin S., Murphy C., Davidson T. M., et al., “Prevalence and Assessment of Qualitative Olfactory Dysfunction in Different Age Groups,” Laryngoscope 106, no. 6 (1996): 739–744, 10.1097/00005537-199606000-00008. PubMed DOI
Nordin S., Bramerson A., Murphy C., et al., “A Scandinavian Adaptation of the Multi‐Clinic Smell and Taste Questionnaire: Evaluation of Questions About Olfaction,” Acta Oto‐Laryngologica 123, no. 4 (2003): 536–542, 10.1080/00016480310001118. PubMed DOI
Olsson P., Berglind N., Bellander T., et al., “Prevalence of Self‐Reported Allergic and Non‐Allergic Rhinitis Symptoms in Stockholm: Relation to Age, Gender, Olfactory Sense and Smoking,” Acta Oto‐Laryngologica 123, no. 1 (2003): 75–80, 10.1080/00016480210000350. PubMed DOI
Frasnelli J. and Hummel T., “Olfactory Dysfunction and Daily Life,” European Archives of Oto‐Rhino‐Laryngology 262, no. 3 (2005): 231–235, 10.1007/s00405-004-0796-y. PubMed DOI
Goldberg A. N., Shea J. A., Deems D. A., et al., “A ChemoSensory Questionnaire for Patients Treated for Cancer of the Head and Neck,” Laryngoscope 115, no. 12 (2005): 2077–2086, 10.1097/01.mlg.0000181467.40764.80. PubMed DOI
Hopkins C., Gillett S., Slack R., et al., “Psychometric Validity of the 22‐Item Sinonasal Outcome Test,” Clinical Otolaryngology 34, no. 5 (2009): 447–454, 10.1111/j.1749-4486.2009.01995.x. PubMed DOI
Croy I., Buschhuter D., Seo H. S., et al., “Individual Significance of Olfaction: Development of a Questionnaire,” European Archives of Oto‐Rhino‐Laryngology 267, no. 1 (2010): 67–71, 10.1007/s00405-009-1047-7. PubMed DOI
Landis B. N., Frasnelli J., Croy I., et al., “Evaluating the Clinical Usefulness of Structured Questions in Parosmia Assessment,” Laryngoscope 120, no. 8 (2010): 1707–1713, 10.1002/lary.20987. PubMed DOI
Takebayashi H., Tsuzuki K., Oka H., et al., “Clinical Availability of a Self‐Administered Odor Questionnaire for Patients With Olfactory Disorders,” Auris, Nasus, Larynx 38, no. 1 (2011): 65–72, 10.1016/j.anl.2010.04.003. PubMed DOI
Wehling E., Nordin S., Espeseth T., et al., “Unawareness of Olfactory Dysfunction and Its Association With Cognitive Functioning in Middle‐Aged and Old Adults,” Archives of Clinical Neuropsychology 26, no. 3 (2011): 260–269, 10.1093/arclin/acr017. PubMed DOI
Pusswald G., Auff E., and Lehrner J., “Development of a Questionnaire for the Assessment of Self‐reported Smell and Taste Disturbances in Aging and Early Neurodegenerative Diseases,” Journal of Alzheimer's Disease 29, no. 4 (2012): 921–929, 10.3233/JAD-2012-111760. DOI
Philpott C. M., Wolstenholme C. R., Goodenough P. C., et al., “Comparison of Subjective Perception with Objective Measurement of Olfactory Function in Patients With Olfactory Disorders,” Clinical Otolaryngology 33, no. 5 (2008): 442–447, 10.1111/j.1749-4486.2008.01896.x. DOI
Mackay‐Sim A. and Doty R. L, “Olfaction in Neurodegenerative Disease,” in Handbook of Olfaction and Gustation, 2nd ed., ed. R. L. Doty (2003), 455–472.
Ottaviano G., Cantone E., D'Errico A., Salvalaggio A., Rizzo S., Pendolino A. L., et al., “Olfactory Outcomes and Patient‐Reported Quality of Life After Endoscopic Sinus Surgery in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study,” Ear, Nose, & Throat Journal 99, no. 7 (2020): 494–503, 10.1177/0145561319876943. DOI
Amezaga J., Alfaro B., Rios Y., et al., “Assessing Taste and Smell Alterations in Cancer Patients Undergoing Chemotherapy According to Treatment,” Supportive Care in Cancer 26, no. 12 (2018): 4077–4086. PubMed
Mattos J. L., Edwards C., Schlosser R. J., et al., “A Brief Version of the Questionnaire of Olfactory Disorders in Patients With Chronic Rhinosinusitis,” International Forum of Allergy & Rhinology 9, no. 10 (2019): 1144–1150. PubMed PMC
Lee J. J., Mahadev A., Kallogjeri D., et al., “Development and Psychometric Validation of the Olfactory Dysfunction Outcomes Rating,” JAMA Otolaryngology – Head & Neck Surgery 148 (2022): 1132–1139, 10.1001/jamaoto.2022.3299. PubMed DOI PMC
Niklassen A. S., Christensen K. B., Fjaeldstad A. W., et al., “Development and Psychometric Validation of the Taste and Smell Tool for Evaluation (TASTE) Questionnaire,” JAMA Otolaryngology – Head & Neck Surgery 148 (2022): 1164–1172, 10.1001/jamaoto.2022.3392. PubMed DOI PMC
Naimi B. R., Hunter S. R., Boateng K., et al., “Patient Insights Into the Diagnosis of Smell and Taste Disorders in the United States,” Medrxiv (2023), 10.1101/2023.09.20.23295861. DOI
Hildebrandt M. E., Møller P. R., Fjældstad A. W., et al., “Postinfectious Conditions Challenge Disease‐Specificity of SNOT‐22,” European Archives of Oto‐Rhino‐Laryngology 281 (2024): 2395–2402, 10.1007/s00405-023-08385-z. PubMed DOI
Schäfer L., Schriever V. A., Croy I., et al., “Human Olfactory Dysfunction: Causes and Consequences,” Cell and Tissue Research 383, no. 1 (2021): 569–579, 10.1007/s00441-020-03381-9. PubMed DOI PMC
Murphy C., “Prevalence of Olfactory Impairment in Older Adults,” Jama 288, no. 18 (2002): 2307, 10.1001/jama.288.18.2307. PubMed DOI
Lundberg M., Maurer R., Tchekmedyian R., et al., “Validation of a Questionnaire Assessing Smell Loss in an International Aspirin‐Exacerbated Respiratory Disease Population,” Allergy and Asthma Proceedings 45, no. 1 (2024): 5–13, 10.2500/aap.2024.45.230079. PubMed DOI
Liu D. T., Welge‐Lüssen A., Besser G., et al., “Assessment of Odor Hedonic Perception: The Sniffin' Sticks Parosmia Test (SSParoT),” Scientific Reports 10, no. 1 (2020): 1–8, 10.1038/s41598-020-74967-0. PubMed DOI PMC
Sekine R., Menzel S., Hähner A., et al., “Assessment of Postviral Qualitative Olfactory Dysfunction Using the Short SSParoT in Patients With and Without Parosmia,” European Archives of Oto‐Rhino‐Laryngology 279, no. 1 (2022): 63–70, 10.1007/s00405-022-07574-6. PubMed DOI PMC